Insider Shareholders with Direct Ownership of Roivant Sciences Ltd. (ROIV)
This section provides a comprehensive overview of the insiders with direct ownership of Roivant Sciences Ltd. (ROIV). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Roivant Sciences Ltd. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Dexcel Pharma Technologies Ltd.
> 10% Shareholder |
4,040,285 | 0 | 102,849,443 $1.16 Billion | 3 |
Nov 10, 2022
Added 3.74%
|
|
Vivek Ramaswamy
> 10% Shareholder |
1,029,735 | 7,509,520 | 51,929,426 $584 Million | 12 |
Jan 02, 2024
Reduced 5.46%
|
|
Mayukh Sukhatme
Pres&Chief Investment Officer |
993,471 | 366,211 | 3,651,985 $41.1 Million | 7 |
Mar 30, 2024
Reduced 9.11%
|
|
Matthew Gline
CEO |
535,312 | 1,085,109 | 1,131,816 $12.7 Million | 43 |
Jun 20, 2024
Reduced 0.96%
|
|
Eric Venker
President & COO |
3,996,950 | 4,928,691 | 457,252 $5.14 Million | 96 |
Jun 20, 2024
Reduced 2.34%
|
|
Richard Pulik
CFO |
105,395 | 45,918 | 290,434 $3.27 Million | 21 |
Jun 28, 2024
Reduced 0.8%
|
|
Rakhi Kumar
Chief Accounting Officer |
525,035 | 575,941 | 212,123 $2.39 Million | 61 |
Jun 20, 2024
Reduced 1.43%
|
| 89,166 | 8,757 | 80,409 $904,601 | 12 |
Apr 24, 2024
Reduced 0.07%
|
|
| 85,268 | 7,732 | 77,536 $872,280 | 13 |
Apr 24, 2024
Reduced 0.38%
|
|
| 69,967 | 750,000 | 69,967 $787,128 | 3 |
Sep 12, 2023
Added 20.3%
|
|
| 69,967 | 0 | 69,967 $787,128 | 2 |
Sep 12, 2023
Added 20.3%
|
|
| 52,142 | 0 | 52,142 $586,597 | 1 |
Sep 15, 2022
Added 50.0%
|
|
| 22,684 | 123 | 22,561 $253,811 | 6 |
Apr 24, 2024
Reduced 0.54%
|
|
| 13,947 | 83 | 13,864 $155,970 | 6 |
Apr 24, 2024
Reduced 0.6%
|
|